Industry News

Globus Medical, Inc., a leading musculoskeletal implant manufacturer, today announced its financial results for the second quarter ended June 30, 2016.. Worldwide sales increased 2.9% as reported to $137.5 million, or 3.1% on a constant currency basis Second quarter net income increased 7.3% to $25.8 million, or 18.8% of sales Diluted earnings per share increased 6.9% to $0.27 Non-GAAP diluted EPS increased 10.6% to $0.29 Non-GAAP Adjusted EBITDA was..."/>
Globus Medical Reports Second Quarter 2016 Results
Alphatec Holdings, Inc., the parent company of Alphatec Spine, Inc., a global provider of spinal fusion technologies, announced today that it has entered into a definitive agreement with Globus Medical, a leading musculoskeletal implant manufacturer, whereby Globus will acquire Alphatec’ s international operations and distribution channel for a purchase price of $80 million. As part of the transaction, Globus has also agreed to provide Alphatec a..."/>
Alphatec Holdings Announces Sale of International Business to Globus Medical
Universal Health Services, Inc. announced today that its reported net income attributable to UHS was $185.6 million, or $1.89 per diluted share, during the second quarter of 2016 as compared to $182.2 million, or $1.80 per diluted share, during the comparable quarter of 2015. Net revenues increased 6.8% to $2.43 billion during the second quarter of 2016 as compared to $2.28 billion during the second quarter of 2015.."/>
Universal Health Services, Inc. Reports 2016 Second Quarter Financial Results
VIVUS, Inc. today announced that it will report financial results and provide a business update for the second quarter of 2016 after the NASDAQ Market closes on Thursday, August 4, 2016. The company will conduct a conference call and an audio webcast at 4:30 pm EST the same day. Date: August 4, 2016 Time: 4:30 PM EST. Dial in: 1 224-357-2386 Dial in: 1 877-359-2916 Audience Passcode: 494 658 37."/>
VIVUS Announces Date of 2016 Second Quarter Business Update and Financial Results Teleconference
Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced it will release second quarter financial results on Tuesday, August 2, 2016 after the market closes. Regulus will host a conference call and webcast on August 2, 2016 at 5:00 p.m. Eastern Time to discuss second quarter financial results and provide a general business update."/>
Regulus to Release Second Quarter Financial Results on August 2, 2016
BioTelemetry, Inc. will release its second quarter 2016 earnings on Tuesday, August 2, 2016 at 4:00 PM Eastern Time.. The BioTelemetry quarterly conference call will be held at 5:00 PM Eastern Time, Tuesday, August 2, 2016. The broadcast will be available through the investor information section of the BioTelemetry website www.gobio.com."/>
BioTelemetry, Inc. to Release Second Quarter 2016 Earnings Results on August 2, 2016
BD Board Declares Dividend
Bard Announces Second Quarter Results
Edwards Lifesciences Corporation, the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today reported financial results for the quarter ended June 30, 2016.. Sales grew 23.1% to $759.3 million; underlying 1 sales were up 21% Global Transcatheter Heart Valve Therapy sales grew 48.7%; underlying grew 45% U.S. THVT sales were up 71.5%; underlying grew 66% GAAP EPS was $0.58, an increase..."/>
Edwards Lifesciences Reports Second Quarter Results
McKesson Corporation today declared a regular dividend of twenty-eight cents per share on Common Stock. The dividend will be payable on October 3, 2016, to stockholders of record on September 1, 2016.. McKesson Corporation, currently ranked 5th on the FORTUNE 500, is a healthcare services and information technology company dedicated to making the business of healthcare run better."/>
McKesson Declares Quarterly Dividend July 26, 2016
Cumberland Pharmaceuticals Inc. announced today that it will release second quarter 2016 financial results after the market closes on Tuesday, August 2, 2016. A conference call and live Internet webcast will be held on Tuesday, August 2, 2016, at 4:30 p.m. Eastern Time to discuss the results. To participate in the call, please dial 877-303-1298 or 253-237-1032."/>
Cumberland Pharmaceuticals To Announce Second Quarter 2016 Financial Results
Alder BioPharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing monoclonal antibody therapeutics, today provided a corporate update and reported its financial and..."/>
Alder BioPharmaceuticals Reports Second Quarter 2016 Financial and Operating Results
Corcept Therapeutics Incorporated today announced it will report second quarter financial results and provide a corporate update on August 2, 2016. The Company will also host a conference call that day at 5:00 p.m. Eastern Time. To participate, dial 1-888-771-4371 from the United States or 1-847-585-4405 internationally approximately 10 minutes before the start of the call. A replay will be available through August 16, 2016 at 1-888-843-7419 from..."/>
Corcept Therapeutics to Announce Second Quarter 2016 Financial Results and Corporate Update and Host Conference Call
Myriad Genetics, Inc. today announced that it will hold its fiscal fourth-quarter 2016 sales and earnings conference call with investors and analysts at 4:30 p.m. ET on Tuesday, August 9, 2016. During the call, Mark C. Capone, president and CEO and Bryan Riggsbee, CFO, will provide an overview of Myriad’ s financial performance for the fiscal fourth-quarter and provide a business update.. To listen to the call, interested parties in the United States may..."/>
Myriad to Announce Fiscal Fourth-Quarter 2016 Financial Results on August 9
Clovis Oncology, Inc. will announce its second quarter 2016 financial results on Monday, August 8, 2016, after the close of the U.S. financial markets. Clovis’ senior management will host a conference call and live audio webcast at 4:30 p.m. ET that day to discuss the company’ s results in greater detail. The conference call is being webcast and can be accessed from the Clovis Oncology website at www.clovisoncology.com."/>
Clovis Oncology to Announce Second Quarter 2016 Financial Results and Host Webcast Conference Call on August 8
Illumina, Inc. today announced its financial results for the second quarter of fiscal year 2016.. Revenue of $600 million, an 11% increase compared to $539 million in the second quarter of 2015 GAAP net income attributable to Illumina stockholders for the quarter of $120 million, or $0.82 per diluted share, compared to $102 million, or $0.69 per diluted share, for the second quarter of 2015 Non-GAAP net income attributable to Illumina stockholders for the quarter of $127..."/>
Illumina Reports Financial Results for Second Quarter of Fiscal Year 2016
SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today that it will release second quarter 2016 financial results after the close of trading on Tuesday, August 9, 2016. The Company’ s management team will host a corresponding conference call beginning at 1:30pm PT/4: 30 pm ET to discuss the financial results and recent business developments.."/>
SeaSpine to Report Second Quarter 2016 Financial Results on August 9, 2016
Kindred Biosciences, Inc., a biopharmaceutical company focused on saving and improving the lives of pets, today announced that it will release its second quarter 2016 financial results on August 8, 2016 after the market close. The Company will host a conference call at 4:30 p.m. Eastern Time/ 1:30 p.m. Pacific Time that day. Interested parties may access the call by dialing toll-free 433-0927 from the US, or 756-4262 internationally, and..."/>
Kindred Biosciences to Announce Second Quarter 2016 Financial Results
NuVasive, Inc., a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today financial results for the quarter ended June 30, 2016.. Revenue increased 16.4% to $236.2 million, or 16.1% on a constant currency basis; GAAP operating profit margin of 25.4%; Non-GAAP operating profit margin up 60 basis points from prior year to 15.9%; GAAP diluted earnings per share of..."/>
NuVasive Reports Second Quarter 2016 Financial Results
Merit Medical Systems, Inc., a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology and endoscopy, announced today that it has appointed David M. Liu, MD, Fellow of the Royal College of Physicians of Canada, diplomate of the American Board of Radiology, and Fellow of the Society of Interventional Radiology, to serve as a..."/>
Merit Medical Announces Appointment of New Director
Molina Healthcare, Inc. and Memorial Hermann Health Plan, Inc. jointly announced today that Molina Healthcare of Texas, Inc., a wholly-owned subsidiary of Molina Healthcare, has entered into an agreement with Memorial Hermann to enhance access to safe, high-quality care for Medicaid, Medicare and CHIP recipients in the greater Houston area. At the closing of the transaction, Molina's approximately 14,000 STAR,..."/>
Molina Healthcare and Memorial Hermann Announce improved access to care for Medicaid, Medicare and CHIP Recipients in Greater Houston
CorVel Corporation’ s quarterly earnings release, CorVel will be conducting a webcast that will be broadcast over the internet on Tuesday, August 2 nd at 11:30 am Eastern Time. CorVel Corporation is a national provider of innovative workers’ compensation, auto, liability and health solutions for employers, third party administrators, insurance companies, and government agencies seeking to control costs and promote positive..."/>
CorVel Announces Earnings Release Webcast
PAVmed Inc., a highly differentiated, multi-product medical device company, announced today that Jan David Wald, Ph.D., Senior Research Analyst at The Benchmark Company, has initiated research coverage on PAVmed. For more information on this report please contact John Borer at investmentbanking@benchmarkcompany.com. PAVmed Inc. is a highly differentiated, multi-product medical device company employing a unique business model designed to advance products from..."/>
PAVmed Announces Initiation of Research Coverage by The Benchmark Company

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Most Popular Sectors in the News
Sectors Articles in the last 7 days
Financials748 Articles
Information Technology722 Articles
Consumer Discretionary647 Articles
Industrials477 Articles
Health Care432 Articles

Sponsored Financial Commentaries

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact , please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.